AzTrials
AzTrials

Symptomatic Periapical PeriodontitisNCT03007342

Effect of Amoxicillin/Clavulanic Acid Combination on Postoperative Endodontic Pain

A study testing Amoxicillin/Clavulanate Potassium 875 mg-125 mg oral tablet in people with Symptomatic Periapical Periodontitis, run by Cairo University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The aim of this prospective, randomized, placebo controlled study is to evaluate the effect of amoxicillin/clavulanic acid combination on post-operative pain and swelling in adult patient with symptomatic apical periodontitis. Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Symptomatic Periapical Periodontitis
What is being tested?
Amoxicillin/Clavulanate Potassium 875 mg-125 mg oral tablet
Type of treatment
Pill or oral medicine
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
78 participants
Where
No sites listed yet
Study dates
Jan 2017to Dec 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Patients with symptomatic apical periodontitis who do not have evidence of spreading infection or systemic involvement.
  • Mandibular posterior teeth with positive response to percussion.
  • Patients with non-contributory systemic condition.
  • Patients who can understand pain scales and able to sign informed consent.

Who cannot join

  • Patients allergic to penicillin.
  • Patients who have a draining sinus tract.
  • Retreatment cases.

Trial locations and contacts

No sites are listed yet.

Ahmed Gomaa, Postgraduate contact

01006610083

ahmed.eltoukhy@dentistry.cu.edu.eg

About this study

Official title: Effect of Amoxicillin/Clavulanic Acid Combination on Postoperative Endodontic Pain in Patients With Symptomatic Apical Periodontitis: A Randomized Controlled Trial

The aim of this prospective, randomized, placebo controlled study is to evaluate the effect of amoxicillin/clavulanic acid combination on post-operative pain and swelling in adult patient with symptomatic apical periodontitis.

Read the detailed description

Medical and dental history will be obtained from all patients participating in this trial. Clinical and radiographic evaluation for each tooth included in this study will be recorded.

Clinical diagnosis of symptomatic apical periodontitis is to be confirmed.

After single-visit root canal treatment, eligible participants will be randomly assigned to one of the following groups: experimental group (taking oral tablet 1000 mg of Amoxicillin/ clavulanic acid combination) or control group (taking placebo tablet).

Each patient will receive a 7-day diary to record postoperative pain and swelling.In case of pain, the participant will be instructed to take an analgesic. Post-operative pain will be measured as a primary outcome on 11-point scale (NRS) at the following time points: 6, 12, 24, 48, 72 hours and 7 days. The occurrence of swelling will be reported by participant as a secondary outcome.

Being tested
Amoxicillin/Clavulanate Potassium 875 mg-125 mg oral tablet, Placebo
Keywords
Amoxicillin, clavulanic acid, Periapical periodontitis, Post-operative pain
Medical subject headings
Periapical Periodontitis, Pain, Postoperative

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Amoxicillin/Clavulanate Potassium 875 mg-125 mg oral tabletDrug

  • PlaceboDrug

Study groups in NCT03007342
Study groupRoleWhat they receive
Experimental groupExperimentalOral tablet 1000 mg of Amoxicillin/ clavulanic acid combination every 12 hours for five days.
Receives: Drug: Amoxicillin/Clavulanate Potassium 875 mg-125 mg oral tablet
control groupPlacebo comparatorOral tablet placebo every 12 hours for five days.
Receives: Drug: Placebo

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Post-operative pain.

    Post-operative pain will be measured by a numerical rating scale (NRS).

    Measured: Up to 7 days after endodontic treatment

Secondary outcomes (1)
  1. Swelling

    The occurrence of Swelling will be measured by a questionnaire.

    Measured: 7 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Jan 2017 (estimated)
  2. Study startJan 2017
  3. Primary completionDec 2017 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
78 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03007342
Sponsor's protocol ID
CEBC-CU-2016-11-168
Status last verified
Dec 2016
First submitted
19 Dec 2016
Last updated
2 Jan 2017
Results posted
No
Data monitoring committee
No
Individual data sharing
No

Publications

  • Henry M, Reader A, Beck M. Effect of penicillin on postoperative endodontic pain and swelling in symptomatic necrotic teeth. J Endod. 2001 Feb;27(2):117-23. doi: 10.1097/00004770-200102000-00016.

    PubMed 11491635
  • Fouad AF, Rivera EM, Walton RE. Penicillin as a supplement in resolving the localized acute apical abscess. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1996 May;81(5):590-5. doi: 10.1016/s1079-2104(96)80054-0.

    PubMed 8734709
  • Cope A, Francis N, Wood F, Mann MK, Chestnutt IG. Systemic antibiotics for symptomatic apical periodontitis and acute apical abscess in adults. Cochrane Database Syst Rev. 2014 Jun 26;(6):CD010136. doi: 10.1002/14651858.CD010136.pub2.

    PubMed 24967571
  • Arteagoitia MI, Barbier L, Santamaria J, Santamaria G, Ramos E. Efficacy of amoxicillin and amoxicillin/clavulanic acid in the prevention of infection and dry socket after third molar extraction. A systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal. 2016 Jul 1;21(4):e494-504. doi: 10.4317/medoral.21139.

    PubMed 26946211

Questions about this trial

What is this clinical trial studying?

A study testing Amoxicillin/Clavulanate Potassium 875 mg-125 mg oral tablet in people with Symptomatic Periapical Periodontitis, run by Cairo University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Jan 2017. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ahmed Gomaa, Postgraduate (01006610083, ahmed.eltoukhy@dentistry.cu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Post-operative pain. (time frame: Up to 7 days after endodontic treatment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03007342, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jan 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in